CA Stock MarketDetailed Quotes

BCT BriaCell Therapeutics Corp

Watchlist
  • 0.760
  • -0.020-2.56%
15min DelayMarket Closed Dec 24 13:00 ET
33.60MMarket Cap-0.61P/E (TTM)

BriaCell Therapeutics Corp Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Oct 31, 2024
(FY)Jul 31, 2024
(Q4)Jul 31, 2024
(Q3)Apr 30, 2024
(Q2)Jan 31, 2024
(Q1)Oct 31, 2023
(FY)Jul 31, 2023
(Q4)Jul 31, 2023
(Q3)Apr 30, 2023
(Q2)Jan 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
8.55%-6.96M
-1.61%-24.13M
63.04%-4.04M
4.65%-5.08M
-87.29%-7.4M
-114.69%-7.61M
-90.20%-23.74M
-228.32%-10.92M
-10.53%-5.33M
-54.59%-3.95M
Net income from continuing operations
-197.83%-5.83M
75.71%-4.93M
48.37%-1.25M
134.57%1.69M
4.61%-11.33M
638.51%5.96M
24.35%-20.3M
-437.06%-2.42M
51.12%-4.9M
-206.46%-11.88M
Operating gains losses
104.82%688.16K
-1,227.46%-28.14M
11.01%-4.53M
-1,922.27%-10.91M
-79.21%1.59M
-246.84%-14.28M
-118.18%-2.12M
-7.73%-5.09M
-109.10%-539.43K
151.56%7.63M
Depreciation and amortization
598.19%26.66K
449.39%83.9K
1,797.43%72.44K
-0.05%3.82K
0.05%3.82K
0.00%3.82K
-0.01%15.27K
-0.03%3.82K
0.03%3.82K
-0.05%3.82K
Remuneration paid in stock
-49.99%266.97K
-17.76%1.8M
-29.21%377.89K
39.48%392.22K
87.43%500.16K
-51.99%533.82K
-28.65%2.19M
-39.20%533.82K
-67.44%281.19K
-67.25%266.84K
Change In working capital
-1,268.76%-2.11M
299.70%7.05M
132.79%1.29M
2,154.47%3.74M
6,070.75%1.84M
-68.15%180.33K
-802.65%-3.53M
-507.17%-3.95M
88.66%-181.88K
-88.77%29.86K
-Change in receivables
29,141.70%736.79K
-14,107.23%-732.58K
-18,411.89%-736.22K
349.87%14.91K
-142.06%-8.74K
54.66%-2.54K
145.36%5.23K
58.45%-3.98K
-147.24%-5.97K
365.02%20.77K
-Change in prepaid assets
-139.65%-371.85K
148.35%2.13M
130.43%1.33M
199.96%888.22K
-428.26%-1.03M
74.05%937.82K
-475.56%-4.4M
-1,179.51%-4.36M
35.52%-888.59K
212.99%312.73K
-Change in payables and accrued expense
-227.51%-2.47M
557.82%5.66M
68.13%703.4K
297.57%2.83M
1,047.78%2.88M
-2,390.30%-754.95K
123.88%860.37K
-27.22%418.36K
398.37%712.68K
-274.72%-303.64K
Cash from discontinued investing activities
Operating cash flow
8.55%-6.96M
-1.61%-24.13M
63.04%-4.04M
4.65%-5.08M
-87.29%-7.4M
-114.69%-7.61M
-90.20%-23.74M
-228.32%-10.92M
-10.53%-5.33M
-54.59%-3.95M
Investing cash flow
Cash flow from continuing investing activities
-75K
-681.8K
-456.8K
-225K
0
0
0
0
0
Net PPE purchase and sale
----
---456.8K
----
----
----
----
--0
----
----
----
Net business purchase and sale
---75K
---225K
--0
---225K
--0
--0
--0
--0
--0
----
Cash from discontinued investing activities
Investing cash flow
---75K
---681.8K
---456.8K
---225K
--0
--0
--0
--0
--0
----
Financing cash flow
Cash flow from continuing financing activities
11.96M
11.75%4.42M
10.47%4.42M
0
0
0
205.65%3.95M
2,603.40%4M
-99.88%1.59K
0
Net common stock issuance
--11.67M
11.79%4.42M
10.47%4.42M
--0
--0
--0
138.86%3.95M
3,996.09%4M
--0
--0
Proceeds from stock option exercised by employees
--293.25K
--0
--0
----
----
--0
-99.98%1.59K
--0
----
----
Cash from discontinued financing activities
Financing cash flow
--11.96M
11.75%4.42M
10.47%4.42M
--0
--0
--0
205.65%3.95M
2,603.40%4M
-99.88%1.59K
--0
Net cash flow
Beginning cash position
-95.94%862.09K
-48.22%21.25M
-96.68%935.69K
-81.36%6.24M
-63.56%13.65M
-48.22%21.25M
-28.33%41.04M
-36.74%28.17M
-30.18%33.5M
-32.51%37.45M
Current changes in cash
164.83%4.93M
-3.02%-20.39M
98.94%-73.61K
0.40%-5.31M
-87.29%-7.4M
-111.86%-7.61M
-21.96%-19.79M
-98.51%-6.92M
-54.29%-5.33M
47.37%-3.95M
End cash Position
-57.55%5.79M
-95.94%862.09K
-95.94%862.09K
-96.68%935.69K
-81.36%6.24M
-63.56%13.65M
-48.22%21.25M
-48.22%21.25M
-36.74%28.17M
-30.18%33.5M
Free cash from
8.55%-6.96M
-3.53%-24.58M
58.86%-4.49M
4.65%-5.08M
-87.29%-7.4M
-114.69%-7.61M
-90.20%-23.74M
-228.32%-10.92M
-10.53%-5.33M
-54.59%-3.95M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Oct 31, 2024(FY)Jul 31, 2024(Q4)Jul 31, 2024(Q3)Apr 30, 2024(Q2)Jan 31, 2024(Q1)Oct 31, 2023(FY)Jul 31, 2023(Q4)Jul 31, 2023(Q3)Apr 30, 2023(Q2)Jan 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 8.55%-6.96M-1.61%-24.13M63.04%-4.04M4.65%-5.08M-87.29%-7.4M-114.69%-7.61M-90.20%-23.74M-228.32%-10.92M-10.53%-5.33M-54.59%-3.95M
Net income from continuing operations -197.83%-5.83M75.71%-4.93M48.37%-1.25M134.57%1.69M4.61%-11.33M638.51%5.96M24.35%-20.3M-437.06%-2.42M51.12%-4.9M-206.46%-11.88M
Operating gains losses 104.82%688.16K-1,227.46%-28.14M11.01%-4.53M-1,922.27%-10.91M-79.21%1.59M-246.84%-14.28M-118.18%-2.12M-7.73%-5.09M-109.10%-539.43K151.56%7.63M
Depreciation and amortization 598.19%26.66K449.39%83.9K1,797.43%72.44K-0.05%3.82K0.05%3.82K0.00%3.82K-0.01%15.27K-0.03%3.82K0.03%3.82K-0.05%3.82K
Remuneration paid in stock -49.99%266.97K-17.76%1.8M-29.21%377.89K39.48%392.22K87.43%500.16K-51.99%533.82K-28.65%2.19M-39.20%533.82K-67.44%281.19K-67.25%266.84K
Change In working capital -1,268.76%-2.11M299.70%7.05M132.79%1.29M2,154.47%3.74M6,070.75%1.84M-68.15%180.33K-802.65%-3.53M-507.17%-3.95M88.66%-181.88K-88.77%29.86K
-Change in receivables 29,141.70%736.79K-14,107.23%-732.58K-18,411.89%-736.22K349.87%14.91K-142.06%-8.74K54.66%-2.54K145.36%5.23K58.45%-3.98K-147.24%-5.97K365.02%20.77K
-Change in prepaid assets -139.65%-371.85K148.35%2.13M130.43%1.33M199.96%888.22K-428.26%-1.03M74.05%937.82K-475.56%-4.4M-1,179.51%-4.36M35.52%-888.59K212.99%312.73K
-Change in payables and accrued expense -227.51%-2.47M557.82%5.66M68.13%703.4K297.57%2.83M1,047.78%2.88M-2,390.30%-754.95K123.88%860.37K-27.22%418.36K398.37%712.68K-274.72%-303.64K
Cash from discontinued investing activities
Operating cash flow 8.55%-6.96M-1.61%-24.13M63.04%-4.04M4.65%-5.08M-87.29%-7.4M-114.69%-7.61M-90.20%-23.74M-228.32%-10.92M-10.53%-5.33M-54.59%-3.95M
Investing cash flow
Cash flow from continuing investing activities -75K-681.8K-456.8K-225K00000
Net PPE purchase and sale -------456.8K------------------0------------
Net business purchase and sale ---75K---225K--0---225K--0--0--0--0--0----
Cash from discontinued investing activities
Investing cash flow ---75K---681.8K---456.8K---225K--0--0--0--0--0----
Financing cash flow
Cash flow from continuing financing activities 11.96M11.75%4.42M10.47%4.42M000205.65%3.95M2,603.40%4M-99.88%1.59K0
Net common stock issuance --11.67M11.79%4.42M10.47%4.42M--0--0--0138.86%3.95M3,996.09%4M--0--0
Proceeds from stock option exercised by employees --293.25K--0--0----------0-99.98%1.59K--0--------
Cash from discontinued financing activities
Financing cash flow --11.96M11.75%4.42M10.47%4.42M--0--0--0205.65%3.95M2,603.40%4M-99.88%1.59K--0
Net cash flow
Beginning cash position -95.94%862.09K-48.22%21.25M-96.68%935.69K-81.36%6.24M-63.56%13.65M-48.22%21.25M-28.33%41.04M-36.74%28.17M-30.18%33.5M-32.51%37.45M
Current changes in cash 164.83%4.93M-3.02%-20.39M98.94%-73.61K0.40%-5.31M-87.29%-7.4M-111.86%-7.61M-21.96%-19.79M-98.51%-6.92M-54.29%-5.33M47.37%-3.95M
End cash Position -57.55%5.79M-95.94%862.09K-95.94%862.09K-96.68%935.69K-81.36%6.24M-63.56%13.65M-48.22%21.25M-48.22%21.25M-36.74%28.17M-30.18%33.5M
Free cash from 8.55%-6.96M-3.53%-24.58M58.86%-4.49M4.65%-5.08M-87.29%-7.4M-114.69%-7.61M-90.20%-23.74M-228.32%-10.92M-10.53%-5.33M-54.59%-3.95M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending CA Stocks
Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.